(Q36379247)

English

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

0 references

William J. Bellini

6

object named as

William J Bellini

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

object named as

Myron J Levin

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

10

object named as

Sharon A Nachman

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stephen I Pelton

11

object named as

Stephen I Pelton

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Mark J Abzug

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Min Qin

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Terence Fenton

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Judy A Beeler

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Susette Audet

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sun Bae Sowers

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

William Borkowsky

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Howard M Rosenblatt

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

12 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

206

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

512-522

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Measles outbreak in Africa--is there a link to the HIV-1 epidemic?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Do children infected with HIV receiving HAART need to be revaccinated?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Measles and measles immunity in children infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Measles antibody: reevaluation of protective titers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Severe measles in immunocompromised patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

30 September 2017

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

28 June 2018

Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

28 June 2018

Role of virus strain dm conventional and enhanced measles plaque neutralization test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

28 June 2018

Population-based study of measles and measles immunization in human immunodeficiency virus-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

28 June 2018

Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Persistence of vaccine-induced antibody to measles 26-33 years after vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia Growth and Development Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Measles antibody in vaccinated human immunodeficiency virus type 1-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Responses to measles immunization in children infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491735

21 September 2018

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS386

21 January 2018

The Urgent Need for Recommendations on Revaccination of HIV‐Infected Children after Successful Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS386

21 January 2018

Measles outbreak in an orphanage: HIV-infected children on antiretroviral therapy are still at risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune responses to measles immunization and the impacts on HIV-infected children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of HIV-infected children with varicella vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody response to measles and rubella vaccine by children with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measles immunity in HIV-infected children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693229

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIS386

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36379247&oldid=1970133022"